Urakami, Toshiharu
Oka, Yusuke
Matono, Takashi
Aoki, Yosuke
Article History
Received: 7 January 2025
Accepted: 13 February 2025
First Online: 18 February 2025
Declarations
:
: This study was conducted according to the principles of the Declaration of Helsinki. The study protocol was approved by the Ethics Committee at Saga University Hospital (approval No 2022-02-R-08). Informed consent was obtained in the form of opt-out on the website because this study only used data collected during clinical practice.
: Not applicable.
: Yosuke Aoki received speaker honoraria from MSD K.K. Takashi Matono. has received speaker honoraria from MSD K.K., Pfizer Japan Inc., Gilead Sciences K.K., and GSK Group of Companies. Toshiharu Urakami and Yusuke Oka have no conflicts of interest.